Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi \u00d6\u011fretim \u00dcyesi de olan, Onkoloji uzman\u0131 Prof. Dr. Kutluk, 1-7 Nisan Ulusal Kanser Haftas\u0131 dolay\u0131s\u0131yla AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, d\u00fcnya geneli kanser istatistiklerine ili\u015fkin bilgileri payla\u015ft\u0131.<\/p>\n
D\u00fcnyada kanser istatistikleriyle ilgili en g\u00fcncel bilgi olan, 2022 y\u0131l\u0131 verilerinin yeni yay\u0131mland\u0131\u011f\u0131n\u0131 belirten Kutluk, “D\u00fcnyada her y\u0131l yakla\u015f\u0131k 20 milyon ki\u015finin kansere yakaland\u0131\u011f\u0131 bildiriliyor. Maalesef bu hastalardan 10 milyonu kaybediliyor ancak 10 milyon ki\u015fi de kurtar\u0131l\u0131yor. Ge\u00e7mi\u015f y\u0131llara bak\u0131ld\u0131\u011f\u0131nda kanserden kurtar\u0131lan ki\u015fi say\u0131s\u0131 her y\u0131l art\u0131yor.” ifadesini kulland\u0131.<\/p>\n
Halihaz\u0131rda d\u00fcnyada kanseri atlatan ve kanser tan\u0131s\u0131 alan toplam 53 milyon ki\u015finin bulundu\u011funu aktaran Kutluk, “T\u00fcrkiye’de ise 2020’de her y\u0131l yakla\u015f\u0131k 230 bin ki\u015fi kansere yakalan\u0131rken, 2022 itibar\u0131yla y\u0131lda 240 bin ki\u015finin kanser oldu\u011fu biliniyor. Maalesef bu hastalar\u0131n da yakla\u015f\u0131k 130 bini kaybediliyor.” diye konu\u015ftu.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/caec1b32-8257-4f58-87b0-6657c62b92b3\/New%20folder%2FNew%20folder%20(17)%2FAA-34155121.jpg\"\/)
<\/p>\n
Prof. Dr. Kutluk, T\u00fcrkiye’de son 5 y\u0131l i\u00e7inde kanser tan\u0131s\u0131 alm\u0131\u015f ve kanserle ya\u015fayan 700 bine yak\u0131n ki\u015finin bulundu\u011funu bildirdi.<\/p>\n
2045’te 32 milyon ki\u015finin kansere yakalanaca\u011f\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor<\/h3>\n
Kanserle ilgili D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc’n\u00fcn (DS\u00d6) gelecek projeksiyonlar\u0131na da i\u015faret eden Kutluk, “DS\u00d6, 2045 y\u0131l\u0131nda d\u00fcnyada 32 milyon ki\u015finin kansere yakalanaca\u011f\u0131n\u0131 ve \u015fu an y\u0131lda 10 milyon olan kanser kaynakl\u0131 \u00f6l\u00fcmlerin 17 milyona \u00e7\u0131kaca\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor. T\u00fcrkiye’de ise kanser vakalar\u0131n\u0131n 2045’te 420 bine, kanserden \u00f6l\u00fcmlerin ise 256 bine ula\u015faca\u011f\u0131n\u0131 biliyoruz.” a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n
Prof. Dr. Kutluk, kanserden kay\u0131plar devam etse de her ge\u00e7en y\u0131l tedavi ba\u015far\u0131s\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 ve dolay\u0131s\u0131yla daha fazla insan\u0131n bu hastal\u0131ktan kurtar\u0131ld\u0131\u011f\u0131n\u0131 vurgulad\u0131.<\/p>\n
En s\u0131k akci\u011fer kanseri g\u00f6r\u00fcl\u00fcyor<\/h3>\n
Yeti\u015fkinlerde en s\u0131k akci\u011fer, meme ve kal\u0131n ba\u011f\u0131rsak kanserinin g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc anlatan Kutluk, “D\u00fcnyada her sene 1,5 milyon civar\u0131nda insan akci\u011fer kanserine yakalan\u0131yor. T\u00fcrkiye’de ise t\u00fct\u00fcn kullan\u0131m\u0131n\u0131n da etkisiyle rakamlar bir miktar \u00fcrk\u00fct\u00fcc\u00fc. Her sene 40 bin ki\u015fi akci\u011fer kanseri oluyor. Bunu 25 bin vakayla meme kanseri ve 21 bin vakayla kal\u0131n ba\u011f\u0131rsak kanseri izliyor.” dedi.<\/p>\n
Kutluk, \u00e7ocuklarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrleri i\u00e7erisinde s\u0131ras\u0131yla l\u00f6semiler, beyin t\u00fcm\u00f6rleri ve lenfomalar\u0131n yer ald\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
D\u00fcnya genelinde yakla\u015f\u0131k 200 bin \u00e7ocu\u011fun kanser tan\u0131s\u0131 ald\u0131\u011f\u0131n\u0131, 200 bin \u00e7ocu\u011fun da hastal\u0131\u011f\u0131na ra\u011fmen tan\u0131 alamad\u0131\u011f\u0131n\u0131n \u00f6ng\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirten Kutluk, “T\u00fcrkiye’de 0-14 ya\u015f grubunda kansere yakalanan 3 bin 500 civar\u0131nda \u00e7ocu\u011fumuz bulunuyor.” ifadesini kulland\u0131.<\/p>\n
Akci\u011fer kanserinin ba\u015f sorumlusu “t\u00fct\u00fcn”<\/h3>\n
Prof. Dr. Tezer Kutluk, kanserde en \u00f6nemli risk fakt\u00f6r\u00fcn\u00fcn t\u00fct\u00fcn ve t\u00fct\u00fcn \u00fcr\u00fcnleri kullan\u0131m\u0131 oldu\u011funa dikkati \u00e7ekerek, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<\/p>\n
“Gerek \u00fclkemiz gerekse d\u00fcnyada g\u00f6r\u00fclen akci\u011fer kanserlerinin y\u00fczde 90’\u0131 t\u00fct\u00fcn kullan\u0131m\u0131 kaynakl\u0131. T\u00fct\u00fcn\u00fcn bir \u015fekilde d\u00fcnyadan elimine edilmesi, yok edilmesi gerekiyor. Bunun d\u0131\u015f\u0131nda kilo fazlal\u0131\u011f\u0131 da kanser a\u00e7\u0131s\u0131ndan \u00f6nemli bir risk fakt\u00f6r\u00fc. D\u00fcnya genelinde her y\u0131l g\u00f6r\u00fclen kanserlerden 500 bininin kilo fazlal\u0131\u011f\u0131, \u015fi\u015fmanl\u0131kla ili\u015fkili oldu\u011fu biliniyor. Ayr\u0131ca UV \u0131\u015f\u0131nlar\u0131n\u0131n yol a\u00e7t\u0131\u011f\u0131, g\u00fcne\u015f \u0131\u015f\u0131\u011f\u0131na a\u015f\u0131r\u0131 maruziyet nedeniyle d\u00fcnyada 170 bin ki\u015finin kansere yakaland\u0131\u011f\u0131 bildiriliyor. Bunlar\u0131n yan\u0131nda d\u00fcnyada her y\u0131l g\u00f6r\u00fclen kanserlerin 750 bini alkol kullan\u0131m\u0131 ili\u015fkili.”<\/p>\n
Kutluk, sa\u011fl\u0131kl\u0131 beslenme, d\u00fczenli egzersiz, t\u00fct\u00fcn kullan\u0131m\u0131ndan uzak durulmas\u0131 ile kanserden korunman\u0131n m\u00fcmk\u00fcn oldu\u011funu belirtti.<\/p>\n
“Eri\u015fkin kanserlerinin tedavisinde gelinebilecek en iyi nokta yakaland\u0131”<\/h3>\n
Kanserde erken tan\u0131 ve tedavinin \u00f6nemine dikkati \u00e7eken Kutluk, T\u00fcrkiye’de meme ve kal\u0131n ba\u011f\u0131rsak kanseri konusunda belirlenen ya\u015f gruplar\u0131nda \u00fccretsiz taramalar\u0131n yap\u0131ld\u0131\u011f\u0131n\u0131 an\u0131msatt\u0131.<\/p>\n
Kutluk, bireylerin mutlaka zaman\u0131 geldi\u011finde kanser taramalar\u0131n\u0131 yapt\u0131rmas\u0131 gerekti\u011finin alt\u0131n\u0131 \u00e7izdi.<\/p>\n
Son y\u0131llarda kanser tedavisinde yeni geli\u015fmelerin ya\u015fand\u0131\u011f\u0131na da de\u011finen Kutluk, radyoterapi ve kemoterapinin yan\u0131nda \u00f6zellikle 2000’li y\u0131llardan itibaren hedef odakl\u0131, bireyselle\u015ftirilmi\u015f tedavilerin \u00f6n plana \u00e7\u0131kt\u0131\u011f\u0131n\u0131 dile getirdi.<\/p>\n
Prof. Dr. Kutluk, \u015funlar\u0131 kaydetti:<\/p>\n
“Halk aras\u0131nda ‘ak\u0131ll\u0131 ila\u00e7’ olarak da an\u0131lan, hedefe y\u00f6nelik, bireyselle\u015ftirilmi\u015f y\u00f6ntemler kanser tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7t\u0131. \u015eu an t\u00fcm kanser t\u00fcrleri i\u00e7in ge\u00e7erli olmasa da bu ila\u00e7lar, tedavi ba\u015far\u0131s\u0131nda \u00f6nemli bir kap\u0131 aralad\u0131. Uzun y\u0131llardan beri eri\u015fkin kanserlerinin tedavisinde gelinebilecek en iyi nokta yakaland\u0131. Hedefe y\u00f6nelik ila\u00e7larla 5 y\u0131ll\u0131k ya\u015fam \u015fans\u0131 y\u00fczde 70 gibi bir orana ula\u015ft\u0131. \u00c7ocuk kanserlerinde ise tedavi ba\u015far\u0131s\u0131 y\u00fczde 85’lere \u00e7\u0131kt\u0131.”<\/p>\n
1947’de kurulan T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi’nin 19 y\u0131ld\u0131r Kanserli Hastalar Kongresi’ni d\u00fczenledi\u011fini aktaran Kutluk, kanserle m\u00fccadelenin hastalar ve yak\u0131nlar\u0131yla birlikte s\u00fcrd\u00fcr\u00fclmesi gerekti\u011fini, kongrenin de bu ama\u00e7la yap\u0131ld\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
Kutluk, bu y\u0131lki kongrenin de 1 Nisan’da Ankara \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130bn-i Sina Hastanesi’nde ger\u00e7ekle\u015ftirilece\u011fini s\u00f6zlerine ekledi.<\/p>\n